Publication Date
3-31-2023
Journal
Cellular and Molecular Life Sciences
DOI
10.1007/s00018-023-04705-y
PMID
37000222
PMCID
PMC10641759
PubMedCentral® Posted Date
3-31-2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Humans, Epilepsy, Intellectual Disability, Mutation, Missense, Receptors, N-Methyl-D-Aspartate, Glutamate receptors, Channelopathy, GRIN, GluN, Pre-M1, Translational study
Abstract
The short pre-M1 helix within the S1-M1 linker (also referred to as the pre-M1 linker) between the agonist-binding domain (ABD, S1) and the M1 transmembrane helix of the NMDA receptor (NMDAR) is devoid of missense variants within the healthy population but is a locus for de novo pathogenic variants associated with neurological disorders. Several de novo variants within this helix have been identified in patients presenting early in life with intellectual disability, developmental delay, and/or epilepsy. In this study, we evaluated functional properties for twenty variants within the pre-M1 linker in GRIN1, GRIN2A, and GRIN2B genes, including six novel missense variants. The effects of pre-M1 variants on agonist potency, sensitivity to endogenous allosteric modulators, response time course, channel open probability, and surface expression were assessed. Our data indicated that virtually all of the variants evaluated altered channel function, and multiple variants had profound functional consequences, which may contribute to the neurological conditions in the patients harboring the variants in this region. These data strongly suggest that the residues within the pre-M1 helix play a key role in channel gating and are highly intolerant to genetic variation.
Included in
Health Services Research Commons, Medical Sciences Commons, Mental and Social Health Commons, Pediatrics Commons